AXIN1 Protein

AXIN1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">AXIN1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[CTNNB1](/proteins/ctnnb1-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CK1α</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Smad3</td>
<td>TGF-β signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">106 edges</a></td>
</tr>
</table>

AXIN1 Protein

Introduction

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">AXIN1 Protein</th>
</tr>
<tr>
<td class="label">Protein</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">[CTNNB1](/proteins/ctnnb1-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[APC](/proteins/apc-protein)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">[GSK3β](/entities/gsk3-beta)</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">CK1α</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">p53</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Smad3</td>
<td>TGF-β signaling</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/carcinoma" style="color:#ef9a9a">Carcinoma</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a>, <a href="/wiki/colorectal-cancer" style="color:#ef9a9a">Colorectal Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">106 edges</a></td>
</tr>
</table>

AXIN1 (Axis Inhibition Protein 1) is a critical scaffold protein that coordinates the assembly of the beta-catenin destruction complex in the canonical Wnt signaling pathway. Originally identified as a negative regulator of Wnt signaling, AXIN1 has emerged as an important player in neurodegenerative diseases through its regulation of beta-catenin, [tau](/proteins/tau) phosphorylation, and various cellular stress responses.
title: AXIN1 Protein
.infobox.infix-protein
; Protein Name
: Axis Inhibition Protein 1
; Gene Symbol
: [AXIN1](/proteins/axin1-protein)
; UniProt ID
: [O15169](https://www.uniprot.org/uniprotkb/O15169)
; PDB ID
: 1DK8
; Molecular Weight
: 86 kDa
; Subcellular Localization
: Cytoplasm, nucleus
; Protein Family
: Axin family

Overview

The AXIN1 gene encodes an 862-amino acid protein that serves as the central scaffold of the beta-catenin destruction complex. AXIN1 brings together APC, GSK3β, and CK1α to form a multiprotein complex that phosphorylates beta-catenin, targeting it for ubiquitination and proteasomal degradation. AXIN1 contains multiple protein interaction domains that enable it to bind various components of the Wnt pathway and other signaling networks[@macdonald2009].

Beyond its canonical role in Wnt signaling, AXIN1 participates in:

• TGF-beta signaling
• p53-dependent apoptosis
• Mitotic checkpoint regulation
• Stress-activated protein kinase pathways

Protein Structure and Functional Domains

AXIN1 contains several distinct functional domains:

N-terminal Region (1-200 aa)

• GSK3β binding domain: Direct interaction with GSK3β
• CK1α binding site: Casein kinase 1 alpha interaction
• DIX domain: Mediates Axin self-oligomerization

Central Region (200-500 aa)

• APC binding sites: Multiple SAMP repeats interact with Axin
• Beta-catenin binding region: Direct interaction with beta-catenin

C-terminal Region (500-862 aa)

• Dimerization domain: Enables Axin self-association
• p53 interaction domain: Participates in apoptosis regulation
• Nuclear export signal: Regulates subcellular localization

Normal Function in the Nervous System

Wnt Signaling Regulation

• Neural progenitor cell proliferation during development
• Neuronal differentiation through beta-catenin-dependent transcription
• Synapse formation and plasticity

Stress Response

• p53-mediated apoptosis following DNA damage
• JNK signaling in response to cellular stress
• Regulation of cell cycle checkpoints

Role in Neurodegenerative Diseases

Alzheimer's Disease

AXIN1 is implicated in [Alzheimer's disease](/diseases/alzheimers-disease) through multiple mechanisms:

Genetic studies have identified AXIN1 polymorphisms associated with AD risk, suggesting its involvement in disease susceptibility[@de2003].

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease-disease):

• AXIN1 may regulate dopaminergic neuron survival
• Interactions with parkin-mediated mitophagy have been reported
• Altered expression in PD brain regions

Amyotrophic Lateral Sclerosis

In ALS, Wnt signaling alterations have been documented, with AXIN1 playing a role in motor neuron survival and neuromuscular junction integrity.

Huntington's Disease

AXIN1 dysregulation has been reported in Huntington's disease models, affecting Wnt-dependent transcription and neuronal survival.

Molecular Mechanisms of AXIN1 Dysfunction in Neurodegeneration

Beta-Catenin Signaling Dysregulation

The canonical Wnt/beta-catenin pathway is critically dependent on AXIN1's scaffold function. In neurodegenerative diseases, AXIN1 dysfunction leads to:

The loss of appropriate beta-catenin regulation contributes to synaptic dysfunction and neuronal death in both AD and PD[@inestrosa2012].

Tau Phosphorylation Connection

AXIN1 directly recruits GSK3β to facilitate [tau](/proteins/tau) phosphorylation:

• AXIN1 serves as a platform bringing GSK3β and tau into proximity
• AXIN1 mutations or dysregulation enhance tau pathology
• This creates a feed-forward loop where tau pathology further disrupts destruction complex function[@liu2011][@palomer2016]

Mitochondrial Dysfunction

AXIN1 influences mitochondrial function through multiple mechanisms:

• Beta-catenin regulates expression of mitochondrial biogenesis factors
• AXIN1 affects PGC-1α signaling and mitochondrial dynamics
• Impaired mitochondrial function contributes to oxidative stress and energy failure in neurodegeneration[@valenti2017]

Neuroinflammation

The Wnt pathway modulates neuroinflammation through effects on [microglia](/entities/microglia):

• AXIN1 regulates cytokine production in response to brain injury
• Wnt signaling influences microglial phenotype transition
• Restoring Wnt signaling may reduce chronic neuroinflammation in AD and PD[@garrido2019]

AXIN1 and Neurogenesis

During adult neurogenesis in the subventricular zone and hippocampal dentate gyrus, AXIN1 plays essential roles:

• Wnt signaling promotes neural stem cell proliferation
• AXIN1 dysregulation leads to reduced neurogenesis in adult brains
• Impaired neurogenesis contributes to cognitive decline in AD

AXIN1 in Protein Aggregation Diseases

Beyond its role in Wnt signaling, AXIN1 intersects with several protein aggregation pathways relevant to neurodegeneration:

Alpha-Synuclein

• Wnt signaling modulates alpha-synuclein aggregation and toxicity
• AXIN1 dysfunction may enhance vulnerability to synucleinopathy
• Cross-talk between Wnt and synuclein pathways suggests therapeutic targets[@song2019]

Amyloid-Beta

• AXIN1 interacts with APP processing pathways
• Beta-catenin can influence BACE1 expression
• AXIN1 dysfunction may exacerbate amyloid pathology

Autophagy and AXIN1

AXIN1 participates in autophagic processes relevant to neurodegeneration:

• The destruction complex components are regulated by autophagy
• AXIN1 turnover is mediated through lysosomal pathways
• Enhancing autophagy may restore proper AXIN1 function in disease[@he2020]

AXIN1 in Dopaminergic Neuron Survival

AXIN1 has emerged as a key regulator of dopaminergic neuron survival in Parkinson's disease:

• AXIN1 expression is altered in the substantia nigra of PD patients
• Wnt/beta-catenin signaling protects dopaminergic neurons from毒素-induced death
• AXIN1 polymorphisms may modify PD risk[@zhang2018]

Therapeutic Implications

Targeting AXIN1 and the destruction complex represents a therapeutic strategy for neurodegenerative diseases:

Small Molecule Approaches

• GSK3β inhibitors: Enhance destruction complex activity and reduce tau phosphorylation
• Wnt pathway modulators: Small molecules that restore proper beta-catenin regulation
• Beta-catenin stabilizers: Selective approaches to maintain appropriate signaling

Gene Therapy Approaches

• Viral vector-mediated AXIN1 expression modulation
• Targeting destruction complex component expression
• Modulating upstream Wnt ligands or receptors

Combination Strategies

• Wnt pathway modulation combined with existing AD/PD therapies
• Multi-target approaches addressing protein aggregation and signaling dysfunction

Wnt/Beta-Catenin-Independent Functions

Beyond its canonical role, AXIN1 participates in beta-catenin-independent signaling:

• Regulation of TGF-beta/Smad signaling
• Control of p53-mediated apoptosis
• These functions may be particularly relevant to neuronal stress responses[@behr2012]

Diagnostic and Biomarker Potential

AXIN1 and Wnt pathway components show promise as biomarkers:

• AXIN1 expression in cerebrospinal fluid may reflect disease progression
• Genetic variants in AXIN1 may modify disease risk
• Monitoring Wnt pathway activity could aid in treatment response

Axin2 and Redundant Functions

AXIN2 (also known as conductin) shares significant homology with AXIN1 and has overlapping functions in the destruction complex:

• AXIN2 can partially compensate for AXIN1 loss
• AXIN2 is expressed in neuronal tissues
• Both proteins may be relevant to neurodegeneration

Interacting Proteins

Research Directions

Current research focuses on:

• Understanding AXIN1's neuron-specific functions
• Developing therapeutics that enhance destruction complex activity
• Exploring AXIN1 as a therapeutic target
• Investigating AXIN1 in protein aggregation diseases

Key Publications

See Also

• [AXIN1 Gene](/proteins/axin1-protein)
• [Wnt Signaling Pathway](/mechanisms/wnt-signaling)
• [Beta-Catenin Destruction Complex](/mechanisms/beta-catenin-destruction-complex)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [GSK3β](/entities/gsk3-beta)
• [Tau Protein](/proteins/tau)

External Links

• [AXIN1 Protein - UniProt](https://www.uniprot.org/uniprot/O15169)
• [AXIN1 Structure - PDB](https://www.rcsb.org/structure/1DK8)
• [NCBI Gene: AXIN1](https://www.ncbi.nlm.nih.gov/gene/351)

Background

The study of Axin1 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References